SCHEMBL23329850

SCHEMBL23329850

CSCCNC(=O)c1cc(-c2cncs2)cc2[nH]ccc12

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 18/20 0.62
▸ HDAC1 Q13547 1/20 0.40
▸ ROCK2 O75116 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23304724 0.85 CD38 (0.61) CD38HDAC1ROCK2ROCK1
SCHEMBL23305725 0.83 CD38 (0.61) CD38HDAC1
SCHEMBL23306003 0.79 CD38 (0.62) CD38HDAC1
SCHEMBL30261809 0.78 CD38 (0.64) CD38
SCHEMBL23304628 0.78 CD38 (0.64) CD38
SCHEMBL23329393 0.78 CD38 (0.47) CD38
SCHEMBL23329326 0.78 CD38 (0.86) CD38
SCHEMBL23329185 0.78 CD38 (0.86) CD38
SCHEMBL23304751 0.77 CD38 (0.85) CD38
SCHEMBL23329112 0.77 CD38 (1.00) CD38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 — — WO disclosed
Send feedback